Advanced Malignant Pleural or Peritoneal Effusion in Patients Treated with Recombinant Adenovirus p53 Injection plus Cisplatin

Author： Dong M   Li X   Hong L-J   Xie R   Zhao H-L   Li K   Wang H-H   Shin W-D   Shen H-J  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.36, Iss.6, 2008-11, pp. : 1273-1278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemotherapeutic management of malignant pleural effusion

By Weatherhead Mark   Antunes George  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1233-1242

Informa Healthcare

Access to resources Recommend Favorite

Pemetrexed/cisplatin worth it in malignant pleural mesothelioma

By  

Inpharma, Vol. 1, Iss. 1627, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Raltitrexed + cisplatin beneficial for malignant pleural mesothelioma

By  

Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Pemetrexed + cisplatin: first-line for malignant pleural mesothelioma

By  

Inpharma, Vol. 1, Iss. 1404, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Increased elimination of paclitaxel by magnesium isoglycyrrhizinate in epithelial ovarian cancer patients treated with paclitaxel plus cisplatin: a pilot clinical study

By Chen Kai   Chen Wan   Chen Xia   Jia Yi   Peng Gui   Chen Li  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 39, Iss. 1, 2014-03 ,pp. : 25-31

Springer Publishing Company

Access to resources Recommend Favorite